|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
CO-ADMINISTRATION WITH HMG-COA REDUCTASE INHIBITORS THAT ARE METABOLIZED BY CYP3A PATHWAY, SUCH AS ATORVASTATIN, INCREASE THE RISK OF MYOPATHY & RHABDOMYOLYSIS
|
CYCLOSPORINE REDUCES ITS METABOLISM, HENCE BIOAVAILABILITY OF THE DRUG IS INCREASED
|
GEMFIBROZIL INCREASED PLASMA CONCENTRATION OF THE DRUG SIGNIFICANTLY
|
CO-ADMINISTRATION MAY INCREASE C MAX & AUC LEVELS OF ALISKIREN BY ABOUT 50%
|